Skip to main content
RMD
NYSE Industrial Applications And Services

ResMed FY2026 10-K: Full-Year Revenue Up 10%, MatrixCare Sale for $490M, Astral Recall Costs $42M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$226.74
Mkt Cap
$32.89B
52W Low
$180.265
52W High
$293.81
52W Position info
26% above low
Off High info
23% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

RMD sits 26% above its 52-week low of $180.265.

Summary

ResMed filed its FY2026 10-K showing 10% revenue growth to $5.65B and net income of $1.52B. The filing details the $490M MatrixCare sale, $335M Noctrix acquisition, and $41.9M Astral recall costs.


Key Events · Earnings and Guidance · RMD

  • FY2026 Revenue Up 10%

    Net revenue increased to $5,653M from $5,146M, driven by 10% growth in Sleep and Breathing Health and 5% in Residential Care Software.

  • MatrixCare Divestiture

    A definitive agreement has been reached to sell MatrixCare for $490M in cash, with closing expected in Q1 FY2027. The business contributed $220M in revenue and $28M in operating profit during FY2026.

  • Noctrix Acquisition

    The acquisition of Noctrix Health for $335M was completed on June 1, 2026, expanding the company's presence in restless legs syndrome treatment.

  • Astral Recall Costs

    Field safety notification expenses of $41.9M were recognized in connection with the Astral device component replacement, impacting gross margin.


Analysis · RMD · Industrial Applications And Services

The annual report confirms robust full-year growth, with revenue up 10% to $5.65B and net income up 9% to $1.52B. It also details the $490M MatrixCare divestiture, the $335M Noctrix acquisition, and $41.9M in Astral field safety notification expenses. Together, these items establish a comprehensive financial baseline and clarify the impact of recent strategic moves and product issues.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RMD was trading at $226.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $32.9B. The 52-week trading range was $180.27 to $293.81. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RMD - Latest Insights

RMD
Oct 29, 2026, 6:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $240.00 info
Change: -$13.00 (-5%) info
Market Cap: $33.692B info
RMD
Oct 29, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $252.83
Real-time Price: $240.00 info
Change: -$12.83 (-5%) info
Market Cap: $33.692B info
RMD
Sep 01, 2026, 4:39 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $231.75
Real-time Price: $240.00 info
Change: +$8.25 (+4%) info
Market Cap: $33.692B info
RMD
Sep 01, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $231.36
Real-time Price: $240.00 info
Change: +$8.64 (+4%) info
Market Cap: $33.692B info
RMD
Aug 17, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $220.37
Real-time Price: $240.00 info
Change: +$19.63 (+9%) info
Market Cap: $33.692B info